These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 20811466)
1. Epilepsy: drug trial design and epilepsy surgery: time for a change? Lhatoo SD; Lüders HO Nat Rev Neurol; 2010 Sep; 6(9):475-6. PubMed ID: 20811466 [No Abstract] [Full Text] [Related]
2. Active control trials for epilepsy: avoiding bias in head-to-head trials. French JA; Kryscio RJ Neurology; 2006 May; 66(9):1294-5. PubMed ID: 16682655 [No Abstract] [Full Text] [Related]
3. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. Powell G; Saunders M; Marson AG Cochrane Database Syst Rev; 2010 Jan; (1):CD007124. PubMed ID: 20091617 [TBL] [Abstract][Full Text] [Related]
4. Alternative analyses for antiepileptic drug trials. Pledger GW; Sahlroot JT Epilepsy Res Suppl; 1993; 10():167-74. PubMed ID: 8251092 [No Abstract] [Full Text] [Related]
5. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. Powell G; Saunders M; Rigby A; Marson AG Cochrane Database Syst Rev; 2014 Dec; (12):CD007124. PubMed ID: 25470302 [TBL] [Abstract][Full Text] [Related]
6. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. Powell G; Saunders M; Marson AG Cochrane Database Syst Rev; 2014 Feb; (2):CD007124. PubMed ID: 24488654 [TBL] [Abstract][Full Text] [Related]
11. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Nevitt SJ; Marson AG; Tudur Smith C Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037 [TBL] [Abstract][Full Text] [Related]
12. Studies of drugs in epilepsy cited by author are not evidence based. Marson AG; Chadwick DW BMJ; 1998 Feb; 316(7132):703. PubMed ID: 9522808 [No Abstract] [Full Text] [Related]
13. Lamotrigine versus carbamazepine monotherapy for epilepsy. Gamble CL; Williamson PR; Marson AG Cochrane Database Syst Rev; 2006 Jan; (1):CD001031. PubMed ID: 16437428 [TBL] [Abstract][Full Text] [Related]
14. Treatment of newly diagnosed epilepsies: the shortcomings of SANAD. Ferrie CD; Grünewald RA; Livingston JH; Panayiotopoulos CP Dev Med Child Neurol; 2008 Apr; 50(4):247. PubMed ID: 18352995 [No Abstract] [Full Text] [Related]
15. Oxcarbazepine versus phenytoin monotherapy for epilepsy. Muller M; Marson AG; Williamson PR Cochrane Database Syst Rev; 2006 Apr; (2):CD003615. PubMed ID: 16625587 [TBL] [Abstract][Full Text] [Related]
16. Clinical experience with oxcarbazepine. Gram L Epilepsia; 1994; 35 Suppl 3():S21-2. PubMed ID: 8156976 [TBL] [Abstract][Full Text] [Related]
17. Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients. Chadwick D; Marson T Epilepsia; 2007 Jul; 48(7):1259-63. PubMed ID: 17442006 [TBL] [Abstract][Full Text] [Related]
18. Protocol design. Wilensky AJ Epilepsy Res Suppl; 1993; 10():107-13. PubMed ID: 8251086 [No Abstract] [Full Text] [Related]
19. Carbamazepine versus phenytoin monotherapy for epilepsy. Tudur Smith C; Marson AG; Clough HE; Williamson PR Cochrane Database Syst Rev; 2002; (2):CD001911. PubMed ID: 12076427 [TBL] [Abstract][Full Text] [Related]
20. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Nevitt SJ; Marson AG; Weston J; Tudur Smith C Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001911. PubMed ID: 28240353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]